TipRanks
BioMarin Pharmaceutical (DE:BM8)
FRANKFURT:BM8

Compare BioMarin Pharmaceutical (BM8) vs. Competitors

1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
BioMarin Pharmaceutical
€55.46
€9.52B
144.45
5.28%
17 Buy
5 Hold
0 Sell
Strong Buy
Jazz Pharmaceuticals
$260.23
$15.01B
14.63
61.45%
18 Buy
1 Hold
0 Sell
Strong Buy
PTC Therapeutics
$73.47
$5.28B
-127.67
-2.98%
8 Buy
1 Hold
1 Sell
Moderate Buy
Ultragenyx Pharmaceutical
$26.46
$1.47B
-2.62
-50.45%
10 Buy
10 Hold
0 Sell
Moderate Buy
Summit Therapeutics
$14.23
$14.36B
-15.33
-26.44%
10 Buy
6 Hold
0 Sell
Moderate Buy
Immunovant
$43.82
$6.62B
-10.73
88.24%
7 Buy
3 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:BM8
BioMarin Pharmaceutical
49.84
3.05
6.52%
JAZZ
Jazz Pharmaceuticals
222.45
84.30
61.02%
PTCT
PTC Therapeutics
62.56
-3.45
-5.23%
RARE
Ultragenyx Pharmaceutical
15.29
-16.37
-51.71%
SMMT
Summit Therapeutics
17.17
-5.48
-24.19%
IMVT
Immunovant
30.26
12.78
73.11%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts